Abstract
The potential and limitations of the non classical metallodrugs with platinum as metal are discussed in this section, focusing not only in their design but in their mechanism of action and interaction with other biomolecules to introduce and encourage the readers on the potential of this field.
Keywords: Metallodrugs, platinum, biomolecules binding, non classical metallodrugs, biomolecules, Current Platinum Complexes, Antitumor Drugs, platinum drugs and their structure-activity relationship, Cisplatin, metallodrug design, platinum chemotherapy, antitumor activity, RULE-BREAKERS, ”, TRANS-PLATINUM COMPLEXES
Current Topics in Medicinal Chemistry
Title: Non-Classical Structures Among Current Platinum Complexes with Potential as Antitumor Drugs
Volume: 11 Issue: 21
Author(s): Adoracion G. Quiroga
Affiliation:
Keywords: Metallodrugs, platinum, biomolecules binding, non classical metallodrugs, biomolecules, Current Platinum Complexes, Antitumor Drugs, platinum drugs and their structure-activity relationship, Cisplatin, metallodrug design, platinum chemotherapy, antitumor activity, RULE-BREAKERS, ”, TRANS-PLATINUM COMPLEXES
Abstract: The potential and limitations of the non classical metallodrugs with platinum as metal are discussed in this section, focusing not only in their design but in their mechanism of action and interaction with other biomolecules to introduce and encourage the readers on the potential of this field.
Export Options
About this article
Cite this article as:
G. Quiroga Adoracion, Non-Classical Structures Among Current Platinum Complexes with Potential as Antitumor Drugs, Current Topics in Medicinal Chemistry 2011; 11 (21) . https://dx.doi.org/10.2174/156802611798040723
DOI https://dx.doi.org/10.2174/156802611798040723 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Engineered Polymer-Based Nanomaterials for Diagnostic, Therapeutic and Theranostic Applications
Mini-Reviews in Medicinal Chemistry Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology No Effect of Metformin on Ovarian Cancer Survival: A Systematic Review and Meta-Analysis of Cohort Studies
Current Pharmaceutical Design Recent Advances in Oncological Submissions of Dendrimer
Current Pharmaceutical Design Targeting Steroid Hormone Receptor Pathways in the Treatment of Hormone Dependent Cancers
Current Pharmaceutical Biotechnology Regulation of UDP Glucuronosyltransferase Genes
Current Drug Metabolism Overcoming Endocrine Resistance in Breast Cancer
Current Cancer Drug Targets Innovations and Opportunities to Improve Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
Current Medicinal Chemistry Needle in a Haystack: Targeting Specific Glucuronidases Amid the Human Microbiome
Current Enzyme Inhibition Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models
Current Medicinal Chemistry Bio-analytical Identification of Key Genes that Could Contribute to the Progression and Metastasis of Osteosarcoma
Current Bioinformatics Signal Transducer and Activator of Transcription 5 (STAT5), a Crucial Regulator of Immune and Cancer Cells
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Cytoprotection and Immunomodulation in Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer
Combinatorial Chemistry & High Throughput Screening Integrins: Regulators of Tissue Function and Cancer Progression
Current Pharmaceutical Design Ovarian Toxicity of Environmental Toxicants
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 5-Lipoxygenase and Cyclooxygenase Inhibitory Dammarane Triterpenoid 1 from Borassus flabellifer Seed Coat Inhibits Tumor Necrosis Factor-α Secretion in LPSInduced THP-1 Human Monocytes and Induces Apoptosis in MIA PaCa-2 Pancreatic Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Toxic Epidermal Necrolysis and Antifolate Drugs in Cancer Chemotherapy
Current Drug Safety Characteristic Alterations of Nuclear Structure and Chromatin Organisation of Cancer Cells Addressed by Proteome Analysis**
Current Proteomics Diffusion-Weighted Magnetic Resonance Imaging in Pelvic Cancer
Current Medical Imaging